Aberrant Myeloid Maturation Identified by Flow Cytometry in Primary Myelofibrosis-Reference-Cited by-同舟云学术

Aberrant Myeloid Maturation Identified by Flow Cytometry in Primary Myelofibrosis

Published:2010-02 Issue:2 Volume:133 Page:314-320
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Feng Bo,Verstovsek Srdan,Jorgensen Jeffrey L.,Lin Pei

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/133/2/314/4994384/ajcpath133-0314.pdf

Reference20 articles.

1. Jacobson RJ Salo A Fialkow PJ . Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood. 1978;51:189–194.

2. Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia

3. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms

4. Thiele J Kvasnicka HM Diehl V . Standardization of bone marrow features: does it work in hematopathology for histological discrimination of different disease patterns? Histol Histopathol. 2005;20:633–644.

5. Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms;Clinical and Experimental Medicine;2024-05-21

2. Immunophenotypic changes in NRBCs of Philadelphia chromosome-negative myeloproliferative neoplasms and its clinical significance;2024-01-12

3. Synoptic Diagnostics of Myeloproliferative Neoplasms: Morphology and Molecular Genetics;Cancers;2021-07-14

4. Transforming growth factor β‐mediated micromechanics modulates disease progression in primary myelofibrosis;Journal of Cellular and Molecular Medicine;2020-09-05

5. Expression of CD markers in JAK2V617F positive myeloproliferative neoplasms: Prognostic significance;Oncology Reviews;2018-10-02